PATENT CLAIM ANALYSIS

Application Number: 15864327
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "094000"]

Abstract:
The present invention provides for methods and compositions for treating and/or preventing cardiac dysfunction by administering to subject a therapeutically effective amount of a bisphosphonate, functional analogue or a pharmaceutically effective salt thereof.

Claim (Index 3):
The composition of  claim 1 , wherein the ejection fraction is increased in the left ventricle.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13393248', '14358468', '14140185', '13203188', '14573211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.740594969636289
- 35 USC 102 Novelty (BERT): 0.5320614827365562
- Combined Prediction Score: 0.7197416209463158
- Mean Citation Score: 219.027706
- Max Citation Score: 334.71255
- Similarity Product: 191.1553336769879

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test